#molecule

Collection of molecule news, found 12 news.

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China, Strengthen Presence in Ophthalmology

 Everest Medicines (HKEX 1952.HK) announced that it has entered into an Asset Purchase Agreement with Corxel ...

ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801's Renoprotective Potential in Oral Presentation

 HighTide Therapeutics, Inc. (2511.HK), an innovative biopharmaceutical company specializing in the development of ...

BioEngine Launches UltraFeed CHO Supplement, Boosting Titers by Up to 48%

Shanghai BioEngine Sci-tech Co., Ltd. announced the launch of UltraFeed, a next-generation fed-batch ...

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide

 Backed by New Medical Association Certification, Insumate® Becomes the Only Bitter Melon Peptide ...

A New Dawn Of Holistic Wellness At The Ritz-Carlton Spa Singapore: Redefining Luxury With The Future Of Skincare

The Ritz-Carlton, Millenia Singapore is pleased to announce the Southeast Asia debut of innovative, ...

BRIN develops eco-friendly, more efficient organic solar cells

fullerene with efficiencies of three to seven percent. Now, it has reached more than 20 percent thanks to the ...

Engine Biosciences and Experimental Drug Development Centre Partner to Advance Novel Therapies to Combat Cancer

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision ...

LintonPharm announces first patient dosed in Phase 1 clinical trial of catumaxomab for Non-Muscle-Invasive Bladder Cancer unresponsive to Bacillus Calmette-Guerin

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

LintonPharm announces authorization from China health authority to proceed with a global Phase 3 trial evaluating Catumaxomab in advanced gastric cancer

- LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell ...

LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement

-     LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into ...

S1P1 Program Assets Generated by Epix Pharmaceuticals, Inc. and Amgen Will Be Offered for Sale

-    Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

-FDA allows use of investigational new drug for life-threatening indications     Edison ...